Rare Cancers Bill 2024-26 Alert Sample


Alert Sample

View the Parallel Parliament page for the Rare Cancers Bill 2024-26

Information since 17 Mar 2025, 11:09 a.m.


Publications and Debates

Date Type Title
16th July 2025 Explanatory Notes HL Bill 124 Explanatory Notes
14th July 2025 1st reading: Minutes of Proceedings
14th July 2025 1st reading
14th July 2025 Impact Assessments Rare Cancers Private Members' Bill Impact Assessment from the Department of Health and Social Care
14th July 2025 Bill HL Bill 124 (as brought from the Commons)
11th July 2025 3rd reading
11th July 2025 Report stage
11th July 2025 Amendment Paper Consideration of Bill Amendments as at 11 July 2025
11th July 2025 Amendment Paper Consideration of Bill Amendments as at 11 July 2025 - large print
11th July 2025 Bill proceedings: Commons Report Stage Proceedings as at 11 July 2025
10th July 2025 Amendment Paper Notices of Amendments as at 10 July 2025
10th July 2025 Amendment Paper Notices of Amendments as at 10 July 2025 - large print
10th July 2025 Selection of amendments: Commons Speaker’s provisional grouping and selection of Amendments - 11 July 2025
10th July 2025 Selection of amendments: Commons Speaker’s provisional grouping and selection of Amendments (large print) - 11 July 2025
9th July 2025 Amendment Paper Notices of Amendments as at 9 July 2025
9th July 2025 Amendment Paper Notices of Amendments as at 9 July 2025 - large print
9th July 2025 Impact Assessments Impact Assessment from the Department of Health and Social Care
2nd July 2025 Committee stage: 1st sitting
2nd July 2025 Bill proceedings: Commons Public Bill Committee Proceedings as at 2 July 2025
1st July 2025 Legislative Consent Motions-devolved legislatures Legislative Consent Motion passed by the Northern Ireland Assembly - 30 June 2025
1st July 2025 Selection of amendments: Commons Chair’s provisional selection and grouping of amendments in Committee - 2 July 2025
30th June 2025 Money resolution

Rare Cancers Bill 2024-26 mentioned

Live Transcript

Note: Cited speaker in live transcript data may not always be accurate. Check video link to confirm.

8 May 2025, 3:56 p.m. - House of Commons
"the aims of the Rare Cancers Bill is to get more patients into clinical trials rare cancers including brain "
Dr Luke Evans MP (Hinckley and Bosworth, Conservative) - View Video - View Transcript
30 Jun 2025, 8 p.m. - House of Commons
">> Thank you. I beg to move that for the purposes of any act resulting from the rare cancers bill, it is "
Money Resolution: Rare Cancers Bill: Money - View Video - View Transcript
30 Jun 2025, 8 p.m. - House of Commons
"from the rare cancers bill, it is expedient to authorise the payment of money provided by Parliament of "
Money Resolution: Rare Cancers Bill: Money - View Video - View Transcript
11 Jul 2025, 12:18 p.m. - House of Commons
"the Rare Cancers Bill will appoint a national specialty lead for rare cancers with the government creating accountability, facilitating "
Gregory Stafford MP (Farnham and Bordon, Conservative) - View Video - View Transcript
11 Jul 2025, 12:38 p.m. - House of Commons
"The Rare Cancers Bill takes concrete and commonsense steps to facilitate research into rare cancers to improve the speed and quality of "
Monica Harding MP (Esher and Walton, Liberal Democrat) - View Video - View Transcript
11 Jul 2025, 12:45 p.m. - House of Commons
"gently push the Minister, even as he supports the Rare Cancers Bill into law, to consider the vitally "
Monica Harding MP (Esher and Walton, Liberal Democrat) - View Video - View Transcript
11 Jul 2025, 12:37 p.m. - House of Commons
"for the Rare Cancers Bill matter, "
Monica Harding MP (Esher and Walton, Liberal Democrat) - View Video - View Transcript
11 Jul 2025, 12:28 p.m. - House of Commons
"We consider the Rare Cancers Bill and let us remember people like "
Gregory Stafford MP (Farnham and Bordon, Conservative) - View Video - View Transcript
14 Jul 2025, 3:22 p.m. - House of Lords
"Lordships. -- Rare Cancers Bill. >> I beg to move that this Bill now "
Business of the House - View Video - View Transcript


Calendar
Wednesday 2nd July 2025 9:25 a.m.
Rare Cancers Bill - Debate
Subject: To consider the Bill
View calendar - Add to calendar
Monday 30th June 2025
HM Treasury
James Murray (Labour (Co-op) - Ealing North)

Money Resolution - Main Chamber
Subject: Rare Cancers Bill: Money
View calendar - Add to calendar


Parliamentary Debates
Rare Cancers Bill
1 speech (1 words)
1st reading
Monday 14th July 2025 - Lords Chamber
Rare Cancers Bill
61 speeches (18,078 words)
Report stage
Friday 11th July 2025 - Commons Chamber
Department of Health and Social Care
Mentions:
1: Luke Evans (Con - Hinckley and Bosworth) I rise to speak on behalf of His Majesty’s official Opposition in support of the Rare Cancers Bill, and - Link to Speech
2: Gregory Stafford (Con - Farnham and Bordon) The Bill addresses those barriers directly.If enacted, the Rare Cancers Bill will appoint a national - Link to Speech
3: Gregory Stafford (Con - Farnham and Bordon) AI-informed cancer prevention if rare cancer research is properly funded.I believe that the Rare Cancers Bill - Link to Speech
4: Monica Harding (LD - Esher and Walton) , particularly for new MPs like me.I do not think I need take up much time restating why the Rare Cancers Bill - Link to Speech

Rare Cancers Bill
16 speeches (3,847 words)
Committee stage: 1st sitting
Wednesday 2nd July 2025 - Public Bill Committees
Department of Health and Social Care
Rare Cancers Bill (Money)
4 speeches (238 words)
Money resolution
Monday 30th June 2025 - Commons Chamber
Department of Health and Social Care
Mentions:
1: Ashley Dalton (Lab - West Lancashire) I beg to move,That, for the purposes of any Act resulting from the Rare Cancers Bill, it is expedient - Link to Speech

Brain Tumours: Research and Treatment
38 speeches (11,582 words)
Thursday 8th May 2025 - Commons Chamber
Department of Health and Social Care
Mentions:
1: Luke Evans (Con - Hinckley and Bosworth) Looking over the debates, I noticed that the Minister said on Second Reading of the Rare Cancers Bill - Link to Speech



Written Answers
Rare Cancers: Clinical Trials
Asked by: Clive Jones (Liberal Democrat - Wokingham)
Friday 18th July 2025

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of patients with (a) suspected and (b) confirmed rare cancers who have access to treatments through clinical trials of medications currently approved for other indications.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is committed to ensuring that all patients, including those with rare cancers, have access to cutting-edge clinical trials, including trials where medicines are repurposed, as well as innovative, lifesaving treatments.

The Department is working to fast-track clinical trials to drive global investment into life sciences, improve health outcomes, and accelerate the development of medicines and therapies of the future, including for rare cancers. The Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority.

The forthcoming National Cancer Plan will include further details on how we will improve outcomes for cancer patients across the country, including patients with rare cancers. It will ensure that more patients have access to the latest treatments and technology, and to clinical trials.

The Government also supports the Rare Cancers Bill and its ambitions to incentivise clinical trials and access to innovative treatments for rare cancers.

Brain: Tumours
Asked by: David Simmonds (Conservative - Ruislip, Northwood and Pinner)
Thursday 10th July 2025

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) the Medicines and Healthcare products Regulatory Agency and (b) the National institute for Health and Care Excellence on access to innovative treatment for patients with brain tumours.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is committed to ensuring that all patients, including those with brain tumours, have access to cutting-edge clinical trials and innovative, lifesaving treatments. As such, officials meet regularly with the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) to cover a range of related issues.

The Department is working with delivery partners and key stakeholders, including the MHRA, to fast-track clinical trials to drive global investment into life sciences, improve health outcomes, and accelerate the development of future medicines and therapies, including for brain tumours.

The MHRA is engaging with public, academic, industry, and patient stakeholder groups to see how the agency can encourage research and product licencing in this underserved area. The MHRA remains focused on enabling safe access to innovative treatment as rapidly as possible.

The Government supports the Rare Cancers Bill and its ambitions to incentivise clinical trials and access to innovative treatments for rare cancers, including brain tumours. As such, the Department has worked closely with the MHRA during the passage of this bill.

NICE makes recommendations on whether new medicines should be routinely funded by the National Health Service based on an assessment of clinical and cost effectiveness. NICE aims, wherever possible, to issue guidance on new medicines close to the time of licensing, and the NHS in England is required to fund NICE recommended medicines. NICE is currently developing technology appraisal guidance for relevant brain cancer therapies.



Bill Documents
Jul. 18 2025
30th Report of the Delegated Powers and Regulatory Reform Committee
Universal Credit Bill 2024-26
Select Committee report

Found: Unauthorised Entry to Football Matches Bill Dogs (Protection of Livestock) (Amendment) Bill Rare Cancers Bill



APPG Publications

Less Survivable Cancers APPG
Wednesday 11th June 2025


Document: APPG Inquiry final report June 2025

Found: The National Cancer Plan and Rare Cancers Bill offer a pivotal moment to strengthen these efforts going